Summary
CVS Health Corporation (CVS) filed an 8-K on August 21, 2019, to announce significant activity regarding its cash tender offers for outstanding debt. The company has set pricing and accepted for purchase substantial principal amounts of its Floating Rate Notes due 2020, 2.800% Senior Notes due 2020, 3.350% Senior Notes due 2021, Floating Rate Notes due 2021, and 2.125% Senior Notes due 2021. These actions are part of previously announced tender offers that commenced on August 8, 2019. Specifically, CVS Health has determined to accept for purchase the maximum aggregate principal amounts of both the 2020 and 2021 maturity notes. The total purchase amounts are capped at $723,339,000 for the 2020 notes and $961,648,000 for the 2021 notes. The early settlement date for these accepted tenders is August 23, 2019, after which no further notes will be purchased under these specific maximum tender offers. This move indicates a strategic effort by CVS Health to manage its debt structure, potentially to optimize its capital expenses or refinance at more favorable rates.
Key Highlights
- 1CVS Health has announced pricing and early results for its cash tender offers for several series of its senior notes and floating rate notes.
- 2The company is accepting for purchase the maximum aggregate principal amounts for both the 2020 and 2021 maturity notes.
- 3The maximum principal amount to be purchased for 2020 notes is $723,339,000.
- 4The maximum principal amount to be purchased for 2021 notes is $961,648,000.
- 5These tender offers were initiated on August 8, 2019.
- 6The early settlement date for accepted tenders is August 23, 2019.
- 7No further notes will be purchased under these maximum tender offers after the early settlement date.